RxDoctor Payments Data

Thomas Jones, MD

Family Medicine · Plainfield, INNPI 1518953033

Payments from drug & device makers

$9,319in general payments, 2019–2025

Across 556 payments — averaging $16.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AbbVie$1K
  • Lilly USA, LLC$1K
  • GSK$715
  • Novartis$572
  • Amgen$523
  • plus $4K from 41 others

What the payments were for

  • Food & beverage$9,298100%
  • Education$210%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,319 in reported general payments places this provider in the 90th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$71,737
Medicare patients
207
Services billed
734

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin109$117,798
EliquisApixaban73$60,210
XareltoRivaroxaban31$31,215
FarxigaDapagliflozin Propanediol22$14,115
JanuviaSitagliptin Phosphate15$13,934
Spiriva HandihalerTiotropium Bromide14$9,171
GlyxambiEmpagliflozin/Linagliptin11$6,829
PremarinEstrogens, Conjugated12$5,071
BelsomraSuvorexant11$4,487
SymbicortBudesonide/Formoterol Fumarate14$4,306
Omeprazole310$4,264
Rosuvastatin Calcium317$3,452
Nebivolol Hcl38$3,371
Metoprolol Succinate288$3,224
Gabapentin178$3,223

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Glyxambi$504$124,627120 claims
PfizerEliquis, Premarin, Paxlovid$457$66,71096 claims
Johnson & JohnsonXarelto$40$31,21531 claims
MerckJanuvia, Belsomra$221$18,42126 claims
AstraZenecaFarxiga, Symbicort$309$18,42136 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$55$1,569180 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Plainfield

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →